KOLLURI KRISHNA KITTU

CIK 000127052148 companiesBALTIMORE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001270521

Recent Transactions

50 trades

Conversion
BillionToOne, Inc.$BLLN
Series A-3 Convertible Preferred Stock
2025-11-07−19,985→ 0 total
Other
BillionToOne, Inc.$BLLN
Common Stock
2025-11-07−1,297,799→ 0 total
Other
BillionToOne, Inc.$BLLN
Common Stock
2025-11-07−242,216→ 0 total
Conversion
BillionToOne, Inc.$BLLN
Series B-2 Convertible Preferred Stock
2025-11-07−320,363→ 0 total
Conversion
BillionToOne, Inc.$BLLN
Series A-6 Convertible Preferred Stock
2025-11-07−2,318,482→ 0 total
Conversion
BillionToOne, Inc.$BLLN
Series B-1 Convertible Preferred Stock
2025-11-07−1,177,800→ 0 total
Conversion
BillionToOne, Inc.$BLLN
Series A-1 Convertible Preferred Stock
2025-11-07−16,746→ 0 total
Conversion
BillionToOne, Inc.$BLLN
Series C Convertible Preferred Stock
2025-11-07−242,216→ 0 total
Conversion
BillionToOne, Inc.$BLLN
Common Stock
2025-11-07+242,216→ 242,216 total
Other
BillionToOne, Inc.$BLLN
Common Stock
2025-11-07−8,333→ 0 total
Conversion
BillionToOne, Inc.$BLLN
Series C-1 Convertible Preferred Stock
2025-11-07−143,914→ 0 total
Other
BillionToOne, Inc.$BLLN
Common Stock
2025-11-07−2,819,490→ 0 total
Other
BillionToOne, Inc.$BLLN
Class A Common Stock
2025-11-07+2,819,490→ 2,819,490 total
Other
BillionToOne, Inc.$BLLN
Class A Common Stock
2025-11-07+8,333→ 8,333 total
Conversion
BillionToOne, Inc.$BLLN
Common Stock
2025-11-07+2,819,490→ 2,819,490 total
Other
BillionToOne, Inc.$BLLN
Class A Common Stock
2025-11-07+242,216→ 242,216 total
Conversion
BillionToOne, Inc.$BLLN
Common Stock
2025-11-07+1,177,800→ 1,297,799 total
Other
BillionToOne, Inc.$BLLN
Class A Common Stock
2025-11-07+1,297,799→ 1,297,799 total
Award
BillionToOne, Inc.$BLLN
Common Stock
2025-11-06+8,333→ 8,333 total
Purchase
Achaogen, Inc.
Common Stock
2016-12-19$13.50/sh+500,000→ 5,215,128 total
Purchase
Tracon Pharmaceuticals, Inc.
Common Stock
2016-11-29$5.75/sh+869,565→ 2,758,039 total
Sale
Ra Pharmaceuticals, Inc.
Common Stock
2016-10-31$13.00/sh−435→ 80,223 total
Conversion
Ra Pharmaceuticals, Inc.
Common Stock
2016-10-31+669,951→ 2,528,401 total
Conversion
Ra Pharmaceuticals, Inc.
Common Stock
2016-10-31+623,210→ 3,151,611 total
Exercise of In-Money
Ra Pharmaceuticals, Inc.
Warrants to Purchase Common Stock
2016-10-31−80,658→ 0 total
Conversion
Ra Pharmaceuticals, Inc.
Series A Preferred Stock
2016-10-31−12,447,605→ 0 total
Purchase
Ra Pharmaceuticals, Inc.
Common Stock
2016-10-31$13.00/sh+338,462→ 3,490,073 total
Conversion
Ra Pharmaceuticals, Inc.
Series B-1 Preferred Stock
2016-10-31−4,689,657→ 0 total
Exercise of In-Money
Ra Pharmaceuticals, Inc.
Common Stock
2016-10-31$0.07/sh+80,658→ 80,658 total
Conversion
Ra Pharmaceuticals, Inc.
Series B-2 Preferred Stock
2016-10-31−4,362,472→ 0 total
Conversion
Ra Pharmaceuticals, Inc.
Common Stock
2016-10-31+1,778,227→ 1,858,450 total
Purchase
Sorrento Tech, Inc.
Warrant to Purchase Common Stock (right to buy)
2016-09-21+5,714,286→ 5,714,286 total
Purchase
Sorrento Tech, Inc.
Series A Convertible Preferred Stock
2016-09-21+4,000→ 4,000 total
Purchase
Sorrento Tech, Inc.
Series A Convertible Preferred Stock
2016-09-21+4,000→ 4,000 total
Purchase
INTERLEUKIN GENETICS INC
Common Stock Warrant (right to buy)
2016-07-29+20,120,724→ 20,120,724 total
Purchase
INTERLEUKIN GENETICS INC
Common Stock
2016-07-29$0.10/sh+20,120,724→ 55,418,811 total
Purchase
ARDELYX, INC.$ARDX
Common Stock
2016-07-18$8.73/sh+763,650→ 2,665,519 total
Purchase
ARDELYX, INC.$ARDX
Common Stock
2016-07-18$8.73/sh+763,651→ 2,665,520 total
Purchase
ARDELYX, INC.$ARDX
Common Stock
2016-07-18$8.73/sh+763,650→ 8,752,543 total
Purchase
TESARO, Inc.
Common Stock
2016-03-18+710,429→ 710,429 total
Purchase
TESARO, Inc.
Common Stock
2016-03-18+710,429→ 9,564,684 total
Purchase
ARDELYX, INC.$ARDX
Common Stock
2016-01-13$10.00/sh+500,000→ 1,901,869 total
Purchase
ARDELYX, INC.$ARDX
Common Stock
2016-01-13$10.00/sh+500,000→ 1,901,869 total
Purchase
ARDELYX, INC.$ARDX
Common Stock
2016-01-13$10.00/sh+500,000→ 7,988,893 total
Purchase
Epizyme, Inc.
Common Stock
2016-01-12$9.00/sh+1,111,111→ 5,854,351 total
Other
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2015-11-11+1,203→ 10,242 total
Other
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2015-11-11−3,820,625→ 3,820,625 total
Other
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2015-11-11−1,172,932→ 0 total
Other
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2015-11-11+10,305→ 20,547 total
Other
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2015-11-11+1,172,932→ 1,172,932 total

Companies

Recent Filings

Address

1119 ST. PAUL STREET

BALTIMORE, MD, 21202

View on SEC.gov